14.11.2024 – 14:00ARTTIC Innovation GmbHLast Call for canSERV Third Open Call FundingOpen CallEin Dokumentmehr
16.10.2024 – 14:00ARTTIC Innovation GmbHEvent Announcement: VIROFIGHT Hybrid SymposiumRegister HereEin Dokumentmehr
24.09.2024 – 12:25RHEACELL GmbH und Co. KGRHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVUmehr
17.09.2024 – 14:05ARTTIC Innovation GmbHLaunch of canSERV Call for Service Provision – "Training the Next Generation of Cancer Researchers"Challenge CallEin Dokumentmehr
09.09.2024 – 09:06Sysmex Europe SE2Fundació Puigvert validates a new tool capable of selecting the most suitable antibiotic for uncomplicated urinary tract infections within 45 minutes.Visit our website!Ein Dokumentmehr
04.09.2024 – 15:13Fördergesellschaft IZB mbH2Record financing rounds at the Munich biotech hubFind out more about the 40+ biotech start-ups at the IZBEin Dokumentmehr
03.09.2024 – 11:10Bosch Healthcare Solutions GmbHNear-patient PCR rapid test for whooping cough for Vivalytic by Bosch now available / World's first fully automated PCR test for detection of B. pertussis, B. parapertussis, B. holmesiimehr
29.08.2024 – 14:03ARTTIC Innovation GmbHcanSERV relaunches Open Call for Service ProvisionOpen CallEin Dokumentmehr
28.08.2024 – 07:34STADA Arzneimittel AGPress release: STADA continues strong growth journey in the first half of 2024Ein Dokumentmehr
18.07.2024 – 11:05Bosch Healthcare Solutions GmbHPCR rapid test for 3 important gastroenteritis pathogens for Vivalytic by Bosch now available / World’s first fully automated PCR test for detection of C. difficile, norovirus, and rotavirus at the sampling pointmehr
02.07.2024 – 14:00ARTTIC Innovation GmbHcanSERV to Accelerate Your Cancer Research - 2 Calls for Service Provision OpencanSERV Challenge Calls2 Dokumentemehr
13.06.2024 – 10:05Sysmex Europe SE4Sysmex’s PA-100 AST System Wins One of the UK’s Biggest Science PrizesVisit our website!Ein Dokumentmehr
05.06.2024 – 17:10Helmholtz Zentrum MünchenNew Study: Father's Diet Before Conception Influences Children's HealthNewsroommehr
28.05.2024 – 14:05ARTTIC Innovation GmbHcanSERV invites applications for "Revolutionising Cancer Patient Care"canSERV Challenge CallEin Dokumentmehr
28.05.2024 – 14:00ARTTIC Innovation GmbH3canSERV invites applications for "Revolutionising Cancer Patient Care"canSERV CallEin Dokumentmehr
21.05.2024 – 08:13Helmholtz Zentrum MünchenNew Study: Night-time heat significantly increases the risk of strokeNewsroommehr
14.05.2024 – 09:01ARTTIC Innovation GmbHLAST CHANCE: canSERV Second Open Call for Cancer Research Service ProvisioncanSERV Open Call Ein Dokumentmehr
23.04.2024 – 14:02ARTTIC Innovation GmbH3canSERV Initiative: EU Consortium Launches Groundbreaking Call to Accelerate Cancer ResearchcanSERV Challenge CallEin Dokumentmehr
10.04.2024 – 11:00Dr. Reddy's Laboratories SADr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatmentmehr
02.04.2024 – 11:10Helmholtz Zentrum MünchenScientists Reveal Adipocyte's Metabolic Role and Identify Treatment Targetsmehr
14.03.2024 – 07:31STADA Arzneimittel AGPress release: STADA continues with double-digit sales and profit growth in 2023Ein Dokumentmehr
13.03.2024 – 16:21FDX Fluid Dynamix GmbH4FDX Fluid Dynamix and Fraunhofer IPK to Collaborate with Lonza on Novel Nanoparticle Formulation Technology Platform FDmiXmehr
28.02.2024 – 15:00RHEACELL GmbH und Co. KGResearch Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘mehr
28.02.2024 – 11:07Helmholtz Zentrum MünchenRising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Targetmehr
23.02.2024 – 10:28Leipzig Tourismus und Marketing GmbH5Pioneering Heart Surgery and Medical Congresses in LeipzigEin Dokumentmehr
22.02.2024 – 13:23Helmholtz Zentrum MünchenTherapeutic Vaccine for Chronic Hepatitis B Enters Clinical TrialMore information on the therapeutic vaccine TherVacBmehr
19.02.2024 – 17:05Helmholtz Zentrum MünchenWhat Our Genetic Information Tells Us About Type 2 Diabetes Risk and ComplicationsLearn more about research at Helmholtz Munichmehr
01.02.2024 – 10:02Sysmex Europe SEStrengthening the Direct Sales and Service System for Business Expansion in ItalyVisit our website!Ein Dokumentmehr
26.01.2024 – 13:50Biomay AGBiomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapymehr